Canada Spends Logo

Explore our Budget 2026 analysis

Grant: CIHR Fellowship

Direct Payment

$150,000.00

Multi-modality cell trafficking imaging using optical bioluminescent imaging, positron emission tomography (PET) and magnetic resonance imaging (MRI)

FY 2008-09

Summary
Cell-based therapies are extremely promising approaches for improved treatments of many diseases. These therapies involve the delivery of specific cell types into damaged tissues, where they may either replace damaged or dead "needed" cells, or initiate the death and removal of abnormal "unwanted" cells. To better monitor the effectiveness of cell-based therapies and to understand ways to improve upon them there is an urgent need to develop ways of assessing the fate of cells once they are administered to patients. This is because the number of cells that effectively "repair" the damaged tissue will be linked to the effectiveness of the treatment and ultimately the patient's health. Cellular imaging is a relatively new and exciting field that offers the opportunity to visualize delivered cells within an intact animal or patient and monitor their function. To date several cellular imaging technologies have been developed through the use of a variety of imaging systems. These include optical imaging technologies such as bioluminescent imaging (BLI), positron emission tomography (PET) and magnetic resonance imaging (MRI). Each of these imaging systems has shown specific advantages for tracking cell fate within entire organisms. MRI can visualize cells at the single cell level and provides excellent images of the anatomy of the body. BLI is relatively easy and affordable. PET imaging is highly quantitative, and along with BLI can be used to monitor the survival and function of delivered cells. We propose to explore ways to combine the strengths of each of these imaging systems in order to have a better "picture" of the effectiveness of cell-based therapies and identify ways to improve them. Our work will provide new ways of studying a variety of cell-based therapies that are being developed for multiple diseases and will hopefully one day lead to tools that can translate into the clinic for better patient management.
Program
CIHR Fellowship
Location
California, United States of America
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
181317
Name
Ronald John A
Region
California
Country
United States of America
Orgtype
Research Institution
Instname2
Circulatory and Respiratory Health
Theme2
Biomedical
Prcname2
Fellowships - Post-PhD
Projecttitle
Multi-modality cell trafficking imaging using optical bioluminescent imaging, positron emission tomography (PET) and magnetic resonance imaging (MRI)
Programtype2
Fellowship Programs
Orgnameinp2
Direct Payment
Cihramount2
$150,000
Cihrequipment2
$0
Programname2
CIHR Fellowship
Keyworddelim
Bioluminescent Imaging; Cell-Based Therapies; Cellular Trafficking; Magnetic Resonance Imaging; Molecular Imaging; Mouse Model; Multi-Modality Imaging; Myocardial Injury; Positron Emission Tomography; Stem Cells
Abstract
Cell-based therapies are extremely promising approaches for improved treatments of many diseases. These therapies involve the delivery of specific cell types into damaged tissues, where they may either replace damaged or dead "needed" cells, or initiate the death and removal of abnormal "unwanted" cells. To better monitor the effectiveness of cell-based therapies and to understand ways to improve upon them there is an urgent need to develop ways of assessing the fate of cells once they are administered to patients. This is because the number of cells that effectively "repair" the damaged tissue will be linked to the effectiveness of the treatment and ultimately the patient's health. Cellular imaging is a relatively new and exciting field that offers the opportunity to visualize delivered cells within an intact animal or patient and monitor their function. To date several cellular imaging technologies have been developed through the use of a variety of imaging systems. These include optical imaging technologies such as bioluminescent imaging (BLI), positron emission tomography (PET) and magnetic resonance imaging (MRI). Each of these imaging systems has shown specific advantages for tracking cell fate within entire organisms. MRI can visualize cells at the single cell level and provides excellent images of the anatomy of the body. BLI is relatively easy and affordable. PET imaging is highly quantitative, and along with BLI can be used to monitor the survival and function of delivered cells. We propose to explore ways to combine the strengths of each of these imaging systems in order to have a better "picture" of the effectiveness of cell-based therapies and identify ways to improve them. Our work will provide new ways of studying a variety of cell-based therapies that are being developed for multiple diseases and will hopefully one day lead to tools that can translate into the clinic for better patient management.
Competitiondate
200902
Approvedterm2
3 yrs 0 mth
Pinamesdelim
Ronald, John A
Approvedterm
3 ans 0 mois
Cihrcontribution2
~ $150,000~ $0~